Regulus Therapeutics shares shot up on Tuesday after the company announced that it had amended and restructured its collaboration and license agreement with Sanofi.
Avon Products, MiMedx, Nevro, and Regulus Therapeutics all posted new 52-week lows Tuesday.
The top analyst upgrades, downgrades and other research calls from Tuesday include American Tower, AutoNation, Biogen, CarMax, Chipotle Mexican Grill, eBay, PG&E, Walgreens and Zions Bancorp.
Regulus Therapeutics, MagneGas, MiMedx, and MetLife all posted new 52-week lows Friday.
The top analyst upgrades, downgrades and other research calls from Wednesday include Apple, Caterpillar, Pfizer, Royal Caribbean, Shopify, Under Armour and Walmart.
DryShips, C.H. Robinson, Regulus Therapeutics and Genuine Parts all posted new 52-week lows on Thursday.
The top analyst upgrades, downgrades and initiations seen on Monday include American Express, Barclays, DuPont, NetApp, Plains All American, Viacom and Disney.
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of December.
Despite Brexit absolutely rocking the market over a week ago, the broad markets made a solid comeback leading most people to believe that this was just one big head fake. Some companies made runs in...
June 28, 2016: Here are four stocks trading with heavy volume among 53 equities making new 52-week lows in Tuesday’s session. NYSE decliners led advancers by more than 5 to 1 and Nasdaq...
Regulus Therapeutics Inc. (NASDAQ: RGLS) saw its shares cut in half early Tuesday morning following news of a clinical hold from the U.S. Food and Drug Administration (FDA). The company announced it...
Over the past week, Zafgen and a few other biotech companies made impressive runs. These moves were the result of positive trial results and an FDA meeting.
Regulus Therapeutics has reported positive interim results from its Phase 2 study for the treatment of hepatitis C virus (HCV) infection.
24/7 Wall St. has collected three big FDA decisions coming up in February and added some color, along with the trading range and price target.
When a sector gets ugly, one of the first things Wall Street looks for is big buyers at much reduced price levels.